CFOR — CapForce Share News
0.000.00%
Last trade - 00:00- $24.36m
- $23.83m
- $30.20m
Brief: Opgen Announced 1-For-20 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Apparel stocks, copper and silver miners
U.S. STOCKS ON THE MOVE-Alphabet, Moderna, chip stocks
Opgen nearly doubles as UTI panel study meets main goal
Brief: OpGen Announces Positive Top Line Data From Clinical Trial For Unyvero Urinary Tract Infection Panel
OpGen Inc reports results for the quarter ended in September - Earnings Summary
Brief: OpGen Reports Third Quarter 2022 Financial Results And Provides Business Update
OpGen Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Opgen To Provide Business Update And Financial Results For The Third Quarter 2022 On November 10Th At 430 P.M. Eastern Standard Time
Brief: Opgen Announces Preliminary Unaudited Revenue And Cash Position For Q3 2022 And Provides Business Update
Brief: OpGen Subsidiary Curetis, Bioversys Sign Collaboration Agreement
Brief: OpGen Announces Successful Completion Of Clinical Trial Enrollment For Unyvero Urinary Tract Infection Panel
U.S. STOCKS ON THE MOVE-Ford, Pagaya Technologies, Nike
U.S. STOCKS ON THE MOVE-Peloton, Pagaya Technologies, AVROBIO, Ford
Brief: Opgen Subsidiary Curetis, FIND Sign Collaboration Agreement For Unyvero A30 RQ Platform
OpGen rises on R&D tie-up with diagnostics alliance FIND
Brief: OpGen- On Aug 30, Nasdaq Notified Co It Had Been Granted Additional 180-Calendar Day Compliance Period, To Regain Compliance With Minimum Bid Price Rule
Brief: Nasdaq Grants OpGen Extension To Meet Minimum Bid Price Requirement
Brief: OpGen Launches Ares Sequencing Services In The U.S.